NYSE:UPC Universe Pharmaceuticals (UPC) Stock Price, News & Analysis → ‘America’s Top Trader’ Who Predicted the Biggest Financial Events of The Last 30 Years, Issues New Warning… (From InvestorPlace) (Ad) Free UPC Stock Alerts $2.92 +0.25 (+9.35%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$2.40▼$2.9450-Day Range$1.67▼$2.9252-Week Range$0.75▼$5.88Volume76,432 shsAverage Volume93,930 shsMarket Capitalization$10.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends Get Universe Pharmaceuticals alerts: Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Universe Pharmaceuticals Stock (NYSE:UPC)Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.Read More UPC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart UPC Stock News HeadlinesFebruary 20, 2024 | investorplace.comWhy Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?February 20, 2024 | investorplace.comWhy Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?February 6, 2024 | investing.comUniverse Pharmaceuticals Inc (UPC)January 30, 2024 | finance.yahoo.comUniverse Pharmaceuticals INC Reports Fiscal Year 2023 Financial ResultsJanuary 10, 2024 | msn.comSeelos Therapeutics, Ampio Pharmaceuticals among healthcare moversJanuary 8, 2024 | msn.comPacific Biosciences of California, Regenxbio among healthcare moversDecember 20, 2023 | morningstar.comUniverse Pharmaceuticals Inc UPCDecember 18, 2023 | finance.yahoo.comUniverse Pharmaceuticals INC's (NASDAQ:UPC) Share Price Boosted 54% But Its Business Prospects Need A Lift TooAugust 4, 2023 | finance.yahoo.comUniverse Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held SharesJuly 27, 2023 | finance.yahoo.comUniverse Pharmaceuticals INC Announces Share ConsolidationJune 6, 2023 | nytimes.comMarvel Cinematic UniverseMay 24, 2023 | forbes.comDid Scientists Actually Spot Evidence Of Another Universe?April 20, 2023 | npr.orgUniverse of ArtApril 18, 2023 | benzinga.comUniverse Pharmaceuticals Stock (NASDAQ:UPC), DividendsMarch 30, 2023 | seekingalpha.comUPC Universe Pharmaceuticals INCFebruary 26, 2023 | foxnews.comPuerto Rican Miss Universe pageant announces first transgender participantFebruary 19, 2023 | bizjournals.comUPC declares insolvency, appointed to receivershipJanuary 18, 2023 | msn.comWhy Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionJanuary 16, 2023 | news.yahoo.comMiss Universe Thailand wears gown made of soda can pull tabs in tribute to her garbage collector parentsJanuary 11, 2023 | time.comHow the Witches and Vampires of the Anne Rice Universe Could Break the Curse of Bad Genre TVDecember 21, 2022 | finance.yahoo.comUniverse Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19November 14, 2022 | finance.yahoo.comUniverse Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price RequirementOctober 10, 2022 | nypost.comMiss USA denies contest was ‘rigged’ as Miss Universe probes pageant scandalSeptember 24, 2022 | newsweek.comAmerican Girl Doll Universe Theory Goes Viral: 'Complicated Implications'August 16, 2022 | finance.yahoo.comUniverse Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022See More Headlines Receive UPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/01/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:UPC CUSIPN/A CIK1809616 Webwww.dzrzy.com Phone86-079-6840-3309FaxN/AEmployees225Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio2.68 Quick Ratio2.43 Sales & Book Value Annual Sales$32.31 million Price / Sales0.33 Cash FlowN/A Price / Cash FlowN/A Book Value$10.91 per share Price / Book0.27Miscellaneous Outstanding Shares3,625,000Free Float1,545,000Market Cap$10.60 million OptionableNot Optionable Beta1.66 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Gang Lai (Age 56)CEO & Chairman Ms. Lin Yang (Age 48)CFO & Director Mr. Baochang Liu (Age 44)Chief Operating Officer Key CompetitorsAcurx PharmaceuticalsNASDAQ:ACXPReviva PharmaceuticalsNASDAQ:RVPHDURECTNASDAQ:DRRXVYNE TherapeuticsNASDAQ:VYNEEyenoviaNASDAQ:EYENView All Competitors UPC Stock Analysis - Frequently Asked Questions How have UPC shares performed in 2024? Universe Pharmaceuticals' stock was trading at $2.01 at the beginning of the year. Since then, UPC stock has increased by 45.4% and is now trading at $2.9230. View the best growth stocks for 2024 here. When did Universe Pharmaceuticals' stock split? Universe Pharmaceuticals's stock reverse split on the morning of Friday, July 28th 2023. The 1-6 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did Universe Pharmaceuticals IPO? Universe Pharmaceuticals (UPC) raised $30 million in an IPO on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at a price of $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO. How do I buy shares of Universe Pharmaceuticals? Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:UPC) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyOn June 10, Nvidia makes its next big moveWeiss RatingsMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryUnlock Explosive Gains with This Defense StockBehind the MarketsElon’s Revenge on BidenTradeSmithClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.